Induction of CTL response by a minimal epitope vaccine in HLA A∗0201/DR1 transgenic mice: dependence on HLA class II restricted TH response

This publication has 43 references indexed in Scilit:

• H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies
  European Journal of Immunology, 1999
• Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees
  European Journal of Immunology, 1997
• Induction of cytotoxic T‐cell response by optimal‐length peptides does not require CD4⁺ T‐cell help
  Immunology, 1996
• Differences and similarities in the A2.1‐restricted cytotoxic T cell repertoire in humans and human leukocyte antigen‐transgenic mice
  European Journal of Immunology, 1996
• In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides
  Molecular Immunology, 1995
• Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.
  Journal of Clinical Investigation, 1995
• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
  European Journal of Immunology, 1993
• Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules.
  The Journal of Experimental Medicine, 1992
• HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides
  Nature, 1992
• Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells
  European Journal of Immunology, 1989